- Home
- LGVN vs NBY Comparison
LGVN vs NBY Comparison
Compare LGVN & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- NBY
- Stock Information
- Founded
- LGVN 2014
- NBY 2000
- Country
- LGVN United States
- NBY United States
- Employees
- LGVN N/A
- NBY N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- NBY
- Sector
- LGVN Health Care
- NBY
- Exchange
- LGVN Nasdaq
- NBY Nasdaq
- Market Cap
- LGVN 16.4M
- NBY 15.7M
- IPO Year
- LGVN 2021
- NBY 2007
- Fundamental
- Price
- LGVN $0.89
- NBY $1.17
- Analyst Decision
- LGVN Strong Buy
- NBY Strong Buy
- Analyst Count
- LGVN 2
- NBY 1
- Target Price
- LGVN $6.50
- NBY $0.85
- AVG Volume (30 Days)
- LGVN 399.0K
- NBY 1.0M
- Earning Date
- LGVN 11-11-2025
- NBY 11-06-2025
- Dividend Yield
- LGVN N/A
- NBY N/A
- EPS Growth
- LGVN N/A
- NBY N/A
- EPS
- LGVN N/A
- NBY 0.41
- Revenue
- LGVN $2,073,000.00
- NBY $9,781,000.00
- Revenue This Year
- LGVN N/A
- NBY $23.91
- Revenue Next Year
- LGVN N/A
- NBY $32.05
- P/E Ratio
- LGVN N/A
- NBY $3.29
- Revenue Growth
- LGVN 68.67
- NBY 113.47
- 52 Week Low
- LGVN $0.63
- NBY $0.46
- 52 Week High
- LGVN $2.48
- NBY $4.44
- Technical
- Relative Strength Index (RSI)
- LGVN 48.25
- NBY 43.47
- Support Level
- LGVN $0.73
- NBY $1.16
- Resistance Level
- LGVN $0.82
- NBY $1.64
- Average True Range (ATR)
- LGVN 0.03
- NBY 0.19
- MACD
- LGVN 0.02
- NBY -0.15
- Stochastic Oscillator
- LGVN 94.35
- NBY 6.99
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.